Maria Nagel
Concepts (352)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Herpesvirus 3, Human | 71 | 2024 | 334 | 18.340 |
Why?
| | Herpes Zoster | 44 | 2024 | 318 | 11.210 |
Why?
| | Temporal Arteries | 17 | 2021 | 45 | 5.740 |
Why?
| | Giant Cell Arteritis | 13 | 2021 | 49 | 5.200 |
Why?
| | DNA, Viral | 14 | 2024 | 362 | 3.160 |
Why?
| | Amyloid beta-Peptides | 7 | 2024 | 222 | 2.680 |
Why?
| | Cerebral Arteries | 8 | 2021 | 60 | 2.620 |
Why?
| | Encephalitis, Varicella Zoster | 9 | 2016 | 17 | 2.540 |
Why?
| | Varicella Zoster Virus Infection | 6 | 2024 | 25 | 2.390 |
Why?
| | Virus Diseases | 8 | 2022 | 217 | 2.240 |
Why?
| | Stroke | 10 | 2023 | 1129 | 2.190 |
Why?
| | Chickenpox | 12 | 2024 | 83 | 2.140 |
Why?
| | Antibodies, Viral | 11 | 2024 | 623 | 1.990 |
Why?
| | Islet Amyloid Polypeptide | 3 | 2021 | 46 | 1.980 |
Why?
| | Herpesviridae Infections | 7 | 2024 | 148 | 1.960 |
Why?
| | Varicellovirus | 7 | 2024 | 17 | 1.770 |
Why?
| | Astrocytes | 4 | 2020 | 210 | 1.620 |
Why?
| | Adventitia | 5 | 2021 | 40 | 1.540 |
Why?
| | Antiviral Agents | 14 | 2022 | 740 | 1.470 |
Why?
| | Virus Activation | 7 | 2024 | 89 | 1.430 |
Why?
| | Antigens, Viral | 6 | 2021 | 180 | 1.420 |
Why?
| | Vascular Diseases | 6 | 2014 | 244 | 1.410 |
Why?
| | Herpesvirus 1, Human | 7 | 2024 | 86 | 1.350 |
Why?
| | Gene Expression Regulation, Viral | 4 | 2019 | 93 | 1.320 |
Why?
| | Virus Latency | 8 | 2024 | 85 | 1.320 |
Why?
| | Arteritis | 2 | 2021 | 27 | 1.300 |
Why?
| | Fibroblasts | 5 | 2021 | 990 | 1.260 |
Why?
| | Adrenal Glands | 2 | 2021 | 78 | 1.200 |
Why?
| | Peptide Fragments | 3 | 2024 | 708 | 1.070 |
Why?
| | Cerebrovascular Disorders | 3 | 2021 | 96 | 1.070 |
Why?
| | Exanthema | 6 | 2022 | 77 | 1.060 |
Why?
| | B7-H1 Antigen | 2 | 2019 | 218 | 0.980 |
Why?
| | Ganglia | 4 | 2019 | 18 | 0.890 |
Why?
| | Vasculitis, Central Nervous System | 3 | 2016 | 14 | 0.850 |
Why?
| | Substance P | 2 | 2020 | 43 | 0.830 |
Why?
| | Host-Pathogen Interactions | 4 | 2020 | 367 | 0.830 |
Why?
| | Neuralgia, Postherpetic | 7 | 2014 | 41 | 0.820 |
Why?
| | Immunoglobulin G | 7 | 2024 | 886 | 0.810 |
Why?
| | Optic Neuropathy, Ischemic | 5 | 2015 | 30 | 0.810 |
Why?
| | Nervous System Diseases | 4 | 2016 | 265 | 0.800 |
Why?
| | Humans | 85 | 2024 | 137514 | 0.790 |
Why?
| | Cerebral Amyloid Angiopathy | 1 | 2021 | 11 | 0.700 |
Why?
| | Cell Death | 1 | 2022 | 370 | 0.670 |
Why?
| | Amyloid | 1 | 2021 | 89 | 0.670 |
Why?
| | Protein Aggregation, Pathological | 1 | 2020 | 19 | 0.670 |
Why?
| | Central Nervous System Infections | 1 | 2020 | 35 | 0.650 |
Why?
| | Vascular Remodeling | 1 | 2021 | 190 | 0.650 |
Why?
| | Antigens, CD | 2 | 2019 | 524 | 0.640 |
Why?
| | Herpes Zoster Ophthalmicus | 2 | 2016 | 5 | 0.640 |
Why?
| | Corneal Keratocytes | 1 | 2019 | 9 | 0.620 |
Why?
| | Aged, 80 and over | 17 | 2020 | 7593 | 0.610 |
Why?
| | Meningitis | 1 | 2020 | 79 | 0.610 |
Why?
| | Epithelium, Corneal | 1 | 2019 | 41 | 0.610 |
Why?
| | Matrix Metalloproteinases | 2 | 2019 | 94 | 0.610 |
Why?
| | Receptors, Neurokinin-1 | 1 | 2018 | 14 | 0.600 |
Why?
| | Cerebral Arterial Diseases | 2 | 2015 | 49 | 0.590 |
Why?
| | Pseudopodia | 1 | 2018 | 26 | 0.590 |
Why?
| | Cells, Cultured | 8 | 2021 | 4206 | 0.580 |
Why?
| | Active Transport, Cell Nucleus | 1 | 2018 | 123 | 0.580 |
Why?
| | Myofibroblasts | 1 | 2019 | 125 | 0.580 |
Why?
| | Asymptomatic Diseases | 2 | 2016 | 87 | 0.570 |
Why?
| | Cadherins | 1 | 2019 | 205 | 0.570 |
Why?
| | Aged | 25 | 2024 | 23798 | 0.560 |
Why?
| | Cytokines | 3 | 2024 | 2095 | 0.550 |
Why?
| | Middle Aged | 27 | 2024 | 33355 | 0.550 |
Why?
| | Burning Mouth Syndrome | 1 | 2016 | 5 | 0.520 |
Why?
| | SUNCT Syndrome | 1 | 2016 | 1 | 0.520 |
Why?
| | Saliva | 3 | 2016 | 242 | 0.510 |
Why?
| | Spinal Cord | 2 | 2018 | 369 | 0.510 |
Why?
| | Trigeminal Ganglion | 4 | 2024 | 26 | 0.510 |
Why?
| | Male | 38 | 2024 | 67718 | 0.510 |
Why?
| | Gene Expression Profiling | 3 | 2021 | 1770 | 0.500 |
Why?
| | Macaca mulatta | 5 | 2024 | 170 | 0.490 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 4 | 2019 | 974 | 0.480 |
Why?
| | Vasculitis | 2 | 2015 | 65 | 0.470 |
Why?
| | Histocompatibility Antigens Class I | 1 | 2016 | 203 | 0.470 |
Why?
| | Interleukin-6 | 1 | 2019 | 778 | 0.470 |
Why?
| | CD8-Positive T-Lymphocytes | 2 | 2019 | 917 | 0.460 |
Why?
| | Tunica Intima | 2 | 2012 | 84 | 0.460 |
Why?
| | Myxovirus Resistance Proteins | 1 | 2014 | 13 | 0.450 |
Why?
| | Acyclovir | 4 | 2020 | 99 | 0.450 |
Why?
| | Stellate Ganglion | 1 | 2014 | 5 | 0.450 |
Why?
| | Ganglia, Sympathetic | 1 | 2014 | 15 | 0.440 |
Why?
| | Herpesvirus 2, Human | 1 | 2014 | 28 | 0.440 |
Why?
| | STAT1 Transcription Factor | 1 | 2014 | 75 | 0.440 |
Why?
| | Steroids | 1 | 2015 | 167 | 0.440 |
Why?
| | Zoster Sine Herpete | 2 | 2012 | 2 | 0.430 |
Why?
| | Herpes Simplex | 3 | 2024 | 93 | 0.420 |
Why?
| | Transcription, Genetic | 3 | 2019 | 1458 | 0.410 |
Why?
| | Aorta | 1 | 2016 | 421 | 0.410 |
Why?
| | Hippocampus | 1 | 2018 | 903 | 0.410 |
Why?
| | Female | 33 | 2024 | 73162 | 0.400 |
Why?
| | Leukocyte Common Antigens | 1 | 2013 | 87 | 0.400 |
Why?
| | Transcriptome | 3 | 2021 | 974 | 0.400 |
Why?
| | Multiplex Polymerase Chain Reaction | 1 | 2013 | 54 | 0.400 |
Why?
| | Middle Cerebral Artery | 1 | 2012 | 53 | 0.400 |
Why?
| | Gene Expression Regulation | 3 | 2019 | 2615 | 0.380 |
Why?
| | Gene Expression | 3 | 2020 | 1505 | 0.340 |
Why?
| | Open Reading Frames | 4 | 2018 | 120 | 0.340 |
Why?
| | Viral Proteins | 6 | 2024 | 346 | 0.340 |
Why?
| | Cell Movement | 3 | 2019 | 972 | 0.330 |
Why?
| | RNA, Messenger | 4 | 2020 | 2838 | 0.330 |
Why?
| | RNA, Viral | 4 | 2012 | 653 | 0.330 |
Why?
| | Pemphigus | 1 | 2009 | 8 | 0.310 |
Why?
| | B-Cell Activating Factor | 1 | 2009 | 21 | 0.310 |
Why?
| | Antigens, CD20 | 1 | 2009 | 29 | 0.310 |
Why?
| | Sequence Analysis, RNA | 2 | 2021 | 451 | 0.300 |
Why?
| | Animals | 20 | 2024 | 37011 | 0.290 |
Why?
| | Primary Cell Culture | 2 | 2022 | 172 | 0.290 |
Why?
| | Inflammation | 5 | 2022 | 2837 | 0.280 |
Why?
| | Endothelium, Vascular | 1 | 2013 | 923 | 0.260 |
Why?
| | CD4-Positive T-Lymphocytes | 3 | 2019 | 1092 | 0.260 |
Why?
| | Alzheimer Disease | 2 | 2023 | 559 | 0.260 |
Why?
| | Retinal Necrosis Syndrome, Acute | 3 | 2013 | 8 | 0.250 |
Why?
| | Adult | 15 | 2024 | 37821 | 0.230 |
Why?
| | Lymphocyte Depletion | 2 | 2019 | 135 | 0.220 |
Why?
| | Brain | 6 | 2024 | 2831 | 0.220 |
Why?
| | Leukocytes | 2 | 2018 | 311 | 0.220 |
Why?
| | Virus Replication | 3 | 2022 | 480 | 0.210 |
Why?
| | Diabetes Mellitus | 1 | 2012 | 1035 | 0.200 |
Why?
| | Monkey Diseases | 2 | 2024 | 20 | 0.200 |
Why?
| | Azadirachta | 1 | 2022 | 3 | 0.190 |
Why?
| | Biopsy | 2 | 2016 | 1132 | 0.190 |
Why?
| | Adrenal Cortex | 1 | 2022 | 29 | 0.190 |
Why?
| | Magnetic Resonance Imaging | 7 | 2016 | 3722 | 0.190 |
Why?
| | Microglia | 1 | 2024 | 251 | 0.190 |
Why?
| | B-Lymphocytes | 3 | 2013 | 847 | 0.190 |
Why?
| | Extracellular Vesicles | 1 | 2024 | 146 | 0.190 |
Why?
| | Exosomes | 1 | 2023 | 103 | 0.190 |
Why?
| | Antibodies, Monoclonal | 1 | 2009 | 1428 | 0.190 |
Why?
| | Tissue Fixation | 1 | 2021 | 36 | 0.180 |
Why?
| | Paraffin Embedding | 1 | 2021 | 32 | 0.180 |
Why?
| | Electrophoresis, Capillary | 2 | 2013 | 20 | 0.180 |
Why?
| | Macaca fascicularis | 1 | 2021 | 66 | 0.180 |
Why?
| | Viral Envelope Proteins | 2 | 2020 | 84 | 0.180 |
Why?
| | Plasma | 1 | 2023 | 213 | 0.180 |
Why?
| | Formaldehyde | 1 | 2021 | 62 | 0.180 |
Why?
| | Histological Techniques | 1 | 2021 | 40 | 0.180 |
Why?
| | Risk Factors | 5 | 2021 | 10356 | 0.180 |
Why?
| | Autoantibodies | 1 | 2009 | 1501 | 0.180 |
Why?
| | Cerebral Angiography | 2 | 2012 | 109 | 0.180 |
Why?
| | Immunosuppressive Agents | 2 | 2020 | 891 | 0.170 |
Why?
| | DNA, Complementary | 1 | 2021 | 269 | 0.170 |
Why?
| | Skin | 2 | 2019 | 751 | 0.170 |
Why?
| | Cell Line | 4 | 2020 | 2852 | 0.170 |
Why?
| | Neuronal Outgrowth | 1 | 2020 | 9 | 0.170 |
Why?
| | Whole-Body Irradiation | 1 | 2020 | 78 | 0.170 |
Why?
| | TRPM Cation Channels | 1 | 2021 | 82 | 0.170 |
Why?
| | Interleukins | 1 | 2022 | 251 | 0.170 |
Why?
| | Olfactory Receptor Neurons | 1 | 2021 | 70 | 0.170 |
Why?
| | Intracellular Space | 1 | 2020 | 69 | 0.160 |
Why?
| | Claudin-1 | 1 | 2019 | 15 | 0.160 |
Why?
| | Anti-Inflammatory Agents | 2 | 2014 | 498 | 0.160 |
Why?
| | Extracellular Space | 1 | 2020 | 121 | 0.160 |
Why?
| | Protein Aggregates | 1 | 2020 | 72 | 0.160 |
Why?
| | Culture Media, Conditioned | 1 | 2019 | 111 | 0.160 |
Why?
| | Prevalence | 3 | 2015 | 2719 | 0.160 |
Why?
| | Programmed Cell Death 1 Ligand 2 Protein | 1 | 2019 | 15 | 0.160 |
Why?
| | Thrombosis | 1 | 2023 | 368 | 0.160 |
Why?
| | Diabetic Neuropathies | 1 | 2020 | 94 | 0.160 |
Why?
| | Tacrolimus | 1 | 2020 | 199 | 0.160 |
Why?
| | Fluorescent Antibody Technique, Indirect | 1 | 2019 | 49 | 0.150 |
Why?
| | Hepatitis A Virus Cellular Receptor 2 | 1 | 2019 | 30 | 0.150 |
Why?
| | Spinal Cord Diseases | 2 | 2010 | 42 | 0.150 |
Why?
| | Case-Control Studies | 2 | 2020 | 3546 | 0.150 |
Why?
| | Neurokinin-1 Receptor Antagonists | 1 | 2018 | 9 | 0.150 |
Why?
| | Spiro Compounds | 1 | 2018 | 14 | 0.150 |
Why?
| | Macrophages | 3 | 2024 | 1548 | 0.150 |
Why?
| | Electrochemical Techniques | 1 | 2019 | 51 | 0.150 |
Why?
| | Diagnosis, Differential | 3 | 2013 | 1486 | 0.150 |
Why?
| | CTLA-4 Antigen | 1 | 2019 | 99 | 0.150 |
Why?
| | Coculture Techniques | 1 | 2019 | 240 | 0.150 |
Why?
| | Glial Fibrillary Acidic Protein | 1 | 2018 | 100 | 0.150 |
Why?
| | DNA | 3 | 2021 | 1460 | 0.140 |
Why?
| | Motor Neurons | 1 | 2020 | 236 | 0.140 |
Why?
| | Risk | 1 | 2020 | 905 | 0.140 |
Why?
| | Herpes Zoster Vaccine | 2 | 2011 | 162 | 0.140 |
Why?
| | Fatal Outcome | 2 | 2015 | 305 | 0.130 |
Why?
| | Aortic Diseases | 1 | 2018 | 117 | 0.130 |
Why?
| | Protein Isoforms | 1 | 2018 | 403 | 0.130 |
Why?
| | Programmed Cell Death 1 Receptor | 1 | 2019 | 252 | 0.130 |
Why?
| | Tumor Necrosis Factor-alpha | 1 | 2022 | 1242 | 0.130 |
Why?
| | Aortitis | 1 | 2016 | 10 | 0.130 |
Why?
| | Adrenal Cortex Hormones | 1 | 2020 | 555 | 0.130 |
Why?
| | Green Fluorescent Proteins | 1 | 2018 | 394 | 0.130 |
Why?
| | Mice, Inbred C57BL | 2 | 2024 | 5792 | 0.130 |
Why?
| | Virology | 2 | 2013 | 25 | 0.130 |
Why?
| | Leukocytes, Mononuclear | 1 | 2019 | 558 | 0.130 |
Why?
| | Real-Time Polymerase Chain Reaction | 2 | 2014 | 344 | 0.120 |
Why?
| | Matrix Metalloproteinase 1 | 1 | 2015 | 22 | 0.120 |
Why?
| | Matrix Metalloproteinase 3 | 1 | 2015 | 28 | 0.120 |
Why?
| | Matrix Metalloproteinase 2 | 1 | 2015 | 56 | 0.120 |
Why?
| | Eye Infections, Viral | 1 | 2015 | 9 | 0.120 |
Why?
| | Neuroglia | 1 | 2016 | 172 | 0.120 |
Why?
| | Histocytochemistry | 1 | 2015 | 82 | 0.120 |
Why?
| | Functional Laterality | 1 | 2016 | 229 | 0.120 |
Why?
| | Pheochromocytoma | 1 | 2016 | 58 | 0.120 |
Why?
| | Oxygen | 1 | 2020 | 943 | 0.120 |
Why?
| | Matrix Metalloproteinase 9 | 1 | 2015 | 132 | 0.120 |
Why?
| | Adrenal Gland Neoplasms | 1 | 2016 | 89 | 0.110 |
Why?
| | STAT2 Transcription Factor | 1 | 2014 | 3 | 0.110 |
Why?
| | Vision Disorders | 2 | 2012 | 141 | 0.110 |
Why?
| | Neurons | 2 | 2016 | 1613 | 0.110 |
Why?
| | Insulin Resistance | 1 | 2023 | 1198 | 0.110 |
Why?
| | Internationality | 1 | 2015 | 155 | 0.110 |
Why?
| | Down-Regulation | 1 | 2016 | 658 | 0.110 |
Why?
| | Interferon-beta | 1 | 2014 | 92 | 0.110 |
Why?
| | Medulla Oblongata | 1 | 2013 | 36 | 0.110 |
Why?
| | Pons | 1 | 2013 | 27 | 0.110 |
Why?
| | Fluorometry | 1 | 2013 | 17 | 0.110 |
Why?
| | Guanine Nucleotide Exchange Factors | 1 | 2014 | 66 | 0.110 |
Why?
| | Risk Assessment | 1 | 2023 | 3439 | 0.100 |
Why?
| | Age Factors | 2 | 2014 | 3301 | 0.100 |
Why?
| | Intracranial Aneurysm | 1 | 2014 | 97 | 0.100 |
Why?
| | Interferon-alpha | 1 | 2014 | 198 | 0.100 |
Why?
| | Polyethylene Glycols | 1 | 2018 | 640 | 0.100 |
Why?
| | Cell Culture Techniques | 1 | 2015 | 363 | 0.100 |
Why?
| | Dementia, Multi-Infarct | 1 | 2012 | 1 | 0.100 |
Why?
| | Myelitis | 1 | 2014 | 107 | 0.100 |
Why?
| | Olfactory Mucosa | 2 | 2024 | 64 | 0.100 |
Why?
| | Polymerase Chain Reaction | 1 | 2016 | 1061 | 0.100 |
Why?
| | Blood Vessels | 1 | 2014 | 188 | 0.100 |
Why?
| | Protein Transport | 1 | 2014 | 443 | 0.100 |
Why?
| | Optic Nerve | 1 | 2012 | 64 | 0.100 |
Why?
| | Methylprednisolone | 1 | 2012 | 85 | 0.100 |
Why?
| | Nanoparticles | 1 | 2018 | 484 | 0.100 |
Why?
| | RNA | 1 | 2019 | 924 | 0.090 |
Why?
| | Apoptosis | 2 | 2019 | 2557 | 0.090 |
Why?
| | Facial Paralysis | 1 | 2011 | 22 | 0.090 |
Why?
| | Immunohistochemistry | 1 | 2016 | 1740 | 0.090 |
Why?
| | Platelet Endothelial Cell Adhesion Molecule-1 | 1 | 2011 | 53 | 0.090 |
Why?
| | Cell Proliferation | 1 | 2019 | 2482 | 0.090 |
Why?
| | Hyperplasia | 1 | 2011 | 175 | 0.090 |
Why?
| | Fetus | 1 | 2015 | 807 | 0.090 |
Why?
| | Cerebrospinal Fluid | 1 | 2011 | 94 | 0.080 |
Why?
| | MicroRNAs | 2 | 2024 | 704 | 0.080 |
Why?
| | Herpes Zoster Oticus | 1 | 2010 | 2 | 0.080 |
Why?
| | Myosin Heavy Chains | 1 | 2011 | 191 | 0.080 |
Why?
| | RNA Stability | 1 | 2011 | 117 | 0.080 |
Why?
| | Comorbidity | 1 | 2015 | 1618 | 0.080 |
Why?
| | In Vitro Techniques | 1 | 2012 | 1108 | 0.080 |
Why?
| | Immunocompromised Host | 1 | 2011 | 203 | 0.080 |
Why?
| | Phosphorylation | 1 | 2014 | 1762 | 0.080 |
Why?
| | Cranial Nerve Diseases | 1 | 2010 | 42 | 0.080 |
Why?
| | Adolescent | 4 | 2024 | 21555 | 0.080 |
Why?
| | Receptors, CCR1 | 1 | 2009 | 4 | 0.080 |
Why?
| | Tumor Necrosis Factor Ligand Superfamily Member 13 | 1 | 2009 | 3 | 0.080 |
Why?
| | Myocytes, Smooth Muscle | 1 | 2011 | 260 | 0.080 |
Why?
| | Neural Stem Cells | 1 | 2011 | 157 | 0.080 |
Why?
| | Actins | 1 | 2011 | 416 | 0.080 |
Why?
| | Biomarkers | 1 | 2020 | 4172 | 0.080 |
Why?
| | Lung | 3 | 2019 | 4066 | 0.080 |
Why?
| | Antibodies, Monoclonal, Murine-Derived | 1 | 2009 | 88 | 0.080 |
Why?
| | Longitudinal Studies | 1 | 2016 | 2857 | 0.080 |
Why?
| | History, 21st Century | 1 | 2009 | 211 | 0.070 |
Why?
| | Laboratories | 1 | 2009 | 113 | 0.070 |
Why?
| | Spectrometry, Fluorescence | 1 | 2009 | 172 | 0.070 |
Why?
| | History, 20th Century | 1 | 2009 | 324 | 0.070 |
Why?
| | Rituximab | 1 | 2009 | 178 | 0.070 |
Why?
| | DNA Primers | 1 | 2009 | 514 | 0.070 |
Why?
| | Chickenpox Vaccine | 1 | 2007 | 73 | 0.070 |
Why?
| | Base Sequence | 1 | 2010 | 2180 | 0.070 |
Why?
| | Neutrophils | 1 | 2012 | 1238 | 0.070 |
Why?
| | Spinal Cord Ischemia | 1 | 2007 | 56 | 0.070 |
Why?
| | Pain | 1 | 2012 | 836 | 0.060 |
Why?
| | Antidepressive Agents | 1 | 2008 | 239 | 0.060 |
Why?
| | Incidence | 1 | 2013 | 2792 | 0.060 |
Why?
| | Molecular Sequence Data | 1 | 2010 | 2901 | 0.060 |
Why?
| | Registries | 1 | 2014 | 2021 | 0.060 |
Why?
| | Predictive Value of Tests | 2 | 2011 | 2039 | 0.060 |
Why?
| | Analgesics | 1 | 2007 | 211 | 0.060 |
Why?
| | Time Factors | 3 | 2014 | 6817 | 0.060 |
Why?
| | Disease Models, Animal | 3 | 2024 | 4295 | 0.060 |
Why?
| | Substance-Related Disorders | 1 | 2014 | 1079 | 0.060 |
Why?
| | Cross-Sectional Studies | 1 | 2015 | 5427 | 0.050 |
Why?
| | Disease Progression | 4 | 2014 | 2755 | 0.050 |
Why?
| | T-Lymphocytes | 1 | 2012 | 1999 | 0.050 |
Why?
| | Recurrence | 2 | 2021 | 1060 | 0.050 |
Why?
| | Sensitivity and Specificity | 1 | 2009 | 1950 | 0.050 |
Why?
| | Sensory Receptor Cells | 1 | 2024 | 104 | 0.050 |
Why?
| | Cell Differentiation | 1 | 2011 | 1979 | 0.050 |
Why?
| | Mice | 4 | 2024 | 17843 | 0.050 |
Why?
| | Presenilin-1 | 1 | 2022 | 32 | 0.050 |
Why?
| | Central Nervous System | 1 | 2024 | 261 | 0.050 |
Why?
| | Tomography, X-Ray Computed | 1 | 2012 | 2681 | 0.050 |
Why?
| | Limonins | 1 | 2022 | 2 | 0.050 |
Why?
| | Plant Bark | 1 | 2022 | 11 | 0.050 |
Why?
| | Fructose | 1 | 2023 | 109 | 0.050 |
Why?
| | Uric Acid | 1 | 2023 | 164 | 0.050 |
Why?
| | Young Adult | 2 | 2024 | 13243 | 0.040 |
Why?
| | Olfactory Bulb | 1 | 2022 | 136 | 0.040 |
Why?
| | Signal Transduction | 1 | 2014 | 5096 | 0.040 |
Why?
| | Analgesics, Opioid | 1 | 2008 | 1002 | 0.040 |
Why?
| | Plant Extracts | 1 | 2022 | 203 | 0.040 |
Why?
| | Cell Hypoxia | 1 | 2020 | 227 | 0.040 |
Why?
| | Infant | 2 | 2024 | 9467 | 0.040 |
Why?
| | Neuroimaging | 1 | 2021 | 291 | 0.040 |
Why?
| | Child, Preschool | 2 | 2024 | 11097 | 0.040 |
Why?
| | Mitochondrial Proteins | 1 | 2020 | 257 | 0.040 |
Why?
| | Tissue Distribution | 1 | 2018 | 330 | 0.040 |
Why?
| | Mice, SCID | 1 | 2018 | 367 | 0.030 |
Why?
| | Glucose | 1 | 2023 | 1018 | 0.030 |
Why?
| | Plasmids | 1 | 2018 | 363 | 0.030 |
Why?
| | Gene Transfer Techniques | 1 | 2018 | 169 | 0.030 |
Why?
| | Induced Pluripotent Stem Cells | 1 | 2020 | 249 | 0.030 |
Why?
| | Action Potentials | 1 | 2020 | 502 | 0.030 |
Why?
| | Child | 3 | 2024 | 22037 | 0.030 |
Why?
| | Lymph Nodes | 1 | 2019 | 493 | 0.030 |
Why?
| | Proteomics | 1 | 2022 | 1113 | 0.030 |
Why?
| | Mice, Transgenic | 1 | 2021 | 2182 | 0.030 |
Why?
| | Dendritic Cells | 1 | 2019 | 488 | 0.030 |
Why?
| | Mice, Inbred BALB C | 1 | 2018 | 1271 | 0.030 |
Why?
| | Ultrasonography, Doppler | 1 | 2014 | 123 | 0.030 |
Why?
| | Mitochondria | 1 | 2020 | 947 | 0.030 |
Why?
| | Basal Ganglia Cerebrovascular Disease | 1 | 2012 | 3 | 0.020 |
Why?
| | Apraxias | 1 | 2012 | 7 | 0.020 |
Why?
| | Visual Acuity | 1 | 2015 | 348 | 0.020 |
Why?
| | Vertebrobasilar Insufficiency | 1 | 2012 | 8 | 0.020 |
Why?
| | Pupil Disorders | 1 | 2012 | 5 | 0.020 |
Why?
| | Dysarthria | 1 | 2012 | 10 | 0.020 |
Why?
| | DNA Mutational Analysis | 1 | 2014 | 401 | 0.020 |
Why?
| | Postmortem Changes | 1 | 2012 | 17 | 0.020 |
Why?
| | Immediate-Early Proteins | 1 | 2012 | 50 | 0.020 |
Why?
| | Valine | 1 | 2012 | 82 | 0.020 |
Why?
| | Gait Disorders, Neurologic | 1 | 2012 | 45 | 0.020 |
Why?
| | Cyclophosphamide | 1 | 2012 | 251 | 0.020 |
Why?
| | Cytopathogenic Effect, Viral | 1 | 2011 | 14 | 0.020 |
Why?
| | Thiouridine | 1 | 2011 | 1 | 0.020 |
Why?
| | Prednisone | 1 | 2012 | 245 | 0.020 |
Why?
| | Phosphonoacetic Acid | 1 | 2011 | 10 | 0.020 |
Why?
| | Memory Disorders | 1 | 2012 | 165 | 0.020 |
Why?
| | Subarachnoid Space | 1 | 2011 | 8 | 0.020 |
Why?
| | Thalamus | 1 | 2012 | 110 | 0.020 |
Why?
| | Half-Life | 1 | 2011 | 166 | 0.020 |
Why?
| | Magnetic Resonance Angiography | 1 | 2012 | 240 | 0.020 |
Why?
| | Fluorescent Antibody Technique | 1 | 2011 | 386 | 0.020 |
Why?
| | Alphaherpesvirinae | 1 | 2009 | 1 | 0.020 |
Why?
| | Vero Cells | 1 | 2009 | 67 | 0.020 |
Why?
| | Drug Therapy, Combination | 1 | 2012 | 1060 | 0.020 |
Why?
| | Immunization | 1 | 2011 | 414 | 0.020 |
Why?
| | Acute Disease | 1 | 2011 | 1008 | 0.020 |
Why?
| | Recovery of Function | 1 | 2012 | 662 | 0.020 |
Why?
| | HeLa Cells | 1 | 2009 | 640 | 0.020 |
Why?
| | Urinary Bladder, Neurogenic | 1 | 2007 | 38 | 0.020 |
Why?
| | Paralysis | 1 | 2007 | 70 | 0.020 |
Why?
| | Treatment Failure | 1 | 2007 | 353 | 0.020 |
Why?
| | Chronic Disease | 1 | 2012 | 1790 | 0.020 |
Why?
| | Diffusion Magnetic Resonance Imaging | 1 | 2007 | 153 | 0.020 |
Why?
| | Arteries | 1 | 2007 | 269 | 0.010 |
Why?
| | Neoplasms | 1 | 2018 | 2666 | 0.010 |
Why?
| | Cell Line, Tumor | 1 | 2011 | 3420 | 0.010 |
Why?
| | Mutation | 1 | 2014 | 3964 | 0.010 |
Why?
|
|
Nagel's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors  People whose addresses are nearby this person. _
|